Alterity Therapeutics

-$0.025 (-3.70%) Today
+$0.0089 (+1.37%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATHE and other ETFs, options, and stocks.

About ATHE

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. The firm focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders.

CEO
David A. Stamler
Employees
11
Headquarters
Melbourne, Victoria (VIC)
Founded
1997

ATHE Key Statistics

Market cap
27.90M
Price-Earnings ratio
—
Dividend yield
—
Average volume
74.03K
High today
$0.70
Low today
$0.6376
Open price
$0.6772
Volume
40.69K
52 Week high
$2.75
52 Week low
$0.5801

ATHE Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure